Cargando…
Cotransfer of regulatory T cells improve the therapeutic effectiveness of mesenchymal stem cells in treating a colitis mouse model
Inflammatory bowel disease (IBD) is a severe inflammatory condition in the colon. To date, clinical solutions for this disease have been limited. Mesenchymal stem cells (MSCs), multipotential cells with immune regulation and anti-inflammatory functions, have been applied to treatment of IBD. However...
Autores principales: | Yu, Yang, Zhao, Tianyu, Yang, Deqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Association for Laboratory Animal Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411303/ https://www.ncbi.nlm.nih.gov/pubmed/28100889 http://dx.doi.org/10.1538/expanim.16-0094 |
Ejemplares similares
-
Errata: Cotransfer of regulatory T cells improve the therapeutic
effectiveness of mesenchymal stem cells in treating a colitis mouse model
por: Yu, Yang, et al.
Publicado: (2022) -
DNA-mediated cotransfer of unlinked mammalian cell markers into mouse L cells
Publicado: (1980) -
Pretreatment with licochalcone a enhances therapeutic activity of rat bone marrow mesenchymal stem cells in animal models of colitis
por: Chen, Meng, et al.
Publicado: (2021) -
Littermate Influence on Infant Growth in Mice: Comparison of SJL/J and ICR as
Cotransferred Carrier Embryos
por: Kaneko, Ryosuke, et al.
Publicado: (2014) -
Osthole improves therapy for osteoporosis through increasing autophagy of
mesenchymal stem cells
por: Zheng, Xuedan, et al.
Publicado: (2019)